T1	intervention 0 52	External beam accelerated partial breast irradiation
T2	control 60 84	whole breast irradiation
T3	eligibility 120 187	women with ductal carcinoma in situ and node-negative breast cancer
T4	location 698 731	Canada, Australia and New Zealand
T5	average-age 744 761	40 years or older
T6	eligibility 762 859	with ductal carcinoma in situ or node-negative breast cancer treated by breast conserving surgery
T7	outcome-Measure 1212 1255	ipsilateral breast tumour recurrence (IBTR)
T8	duration 1647 1686	Between Feb 7, 2006, and July 15, 2011,
T9	No-of-participants 1699 1703	2135
T10	intervention-participants 1711 1715	1070
T11	control-participants 1759 1763	1065
T12	outcome 2346 2377	8-year cumulative rates of IBTR
T13	intervention-value 2383 2387	3·0%
T14	control-value 2427 2431	2·8%
T15	outcome 2485 2526	HR for APBI versus whole breast radiation
T16	outcome 2556 2580	Acute radiation toxicity
T18	intervention-participants 2700 2704	1070
T20	control-participants 2759 2763	1065
T21	outcome 2785 2808	Late radiation toxicity
T23	intervention-participants 2901 2905	1070
T25	control-participants 2960 2964	1065
T26	outcome 2986 3002	Adverse cosmesis
T27	outcome 3125 3135	at 3 years
T28	outcome 3183 3190	5 years
T29	outcome 3215 3222	7 years
T17	intervention-value 2687 2690	300
T30	intervention-value 2692 2695	28%
T19	control-value 2746 2749	484
T31	control-value 2751 2754	45%
T22	intervention-value 2888 2891	346
T32	intervention-value 2893 2896	32%
T24	control-value 2947 2950	142
T33	control-value 2952 2955	13%
